Form 4 for BSX Boston Scientific
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001225208-25-001679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-13 | 2025-02-11 | BSX | Brennan Daniel J. | EVP, CFO | A - Grant | $0.00 | +33.9K | 257.9K | +15% | $0 |
| D | 2025-02-13 | 2025-02-11 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $105.98 | -16.4K | 241.5K | -6% | -$1.74M |
| D | 2025-02-13 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $16.31 | +15.1K | 256.5K | +6% | +$246.1K |
| D | 2025-02-13 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.07 | -15.1K | 241.5K | -6% | -$1.59M |
| D | 2025-02-13 | 2025-02-12 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | -15.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | A | A | 33,944 | $0.00 | 257,865 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-11 | F | D | 16,414 | $105.98 | 241,451 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-12 | M | A | 15,087 | $16.31 | 256,538 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-12 | S | D | 15,087 | $105.07 | 241,451 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.778 to $105.28, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-12 | M | D | 15,087 | $0.00 | 0 | D | $16.31 · — to 2025-02-23 | 15,087 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |